African Life Sciences: Can AI and Precision Medicine Power its Growth?
There are no long-term forecasts for life sciences growth across Africa. For a continent undergoing such dramatic demographic and economic transformation, that gap is striking. Professor Richard Barker reports from Accra on what he saw — and why the case for optimism is stronger than it appears.
Why Healthy Longevity Clinics Struggle to Sustainably Scale — A Systems Perspective
Why do so many healthy longevity clinics struggle to achieve sustainable scale? Using a systems perspective and the 7S model, this article explores why success depends less on clinical intent and more on coherent organisational design.
The State of Healthy Longevity in 2026: Ten Wicked Issues Revisited
A clear-eyed review of healthy longevity at the close of 2025, revisiting ten wicked issues to assess progress, persistent gaps and what will shape the field’s trajectory in 2026 and beyond.
Guest Edition: ARDD 2025 - Big Pharma Discovers Healthy Longevity
At ARDD 2025, the world’s leading ageing-science conference, GLP-1 momentum and major pharma participation highlighted the accelerating shift toward healthy longevity. Key themes included gerotherapeutics, AI-driven breakthroughs, epigenetic clocks, and global clinical advances.
Reflecting on 2023 and Charting the Course for 2024
Explore the global rise of healthy longevity in 2023 and what lies ahead in 2024. Prof Richard Barker discusses key trends, scientific advancements, and the future of healthspan programs.
Speaking at the NY Founders Forum: Precision Medicine, Longevity Science, and AI
Prof Richard Barker shares insights from the NY Founders Forum on precision medicine, longevity science, and AI. Learn about key discussions with industry leaders and innovative healthspan technologies.
Artificial Intelligence in the Global Spotlight: Opportunities and Risks
Explore Prof Richard Barker’s insights on AI in healthcare from the Bletchley Park Global Summit. Learn about AI’s benefits for healthy longevity, regulatory considerations, and the future of precision medicine.